Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Angiogenesis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00511511
What this trial is testing

Angiogenesis Inhibitors and Hypertension: Clinical Aspects

Who this might be right for
Hypertension
Erasmus Medical Center 80
Not applicableStudy completedNCT02514564
What this trial is testing

The Effects of Aerobic Exercise in Microvascular Endothelium Function in Patients With Cardiovascular Diseases

Who this might be right for
Cardiovascular Diseases
Instituto Nacional de Cardiologia de Laranjeiras 115
Testing effectiveness (Phase 2)UnknownNCT06134193
What this trial is testing

Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract Cancer

Who this might be right for
CarcinomaIntrahepatic CholangiocarcinomaGallbladder Cancer+5 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 41
Early research (Phase 1)UnknownNCT05273814
What this trial is testing

Study of Chemotherapy and PD-1 Inhibitor Combination With Anti-angiogenesis to Treat Elderly Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 30
Not applicableUnknownNCT03979833
What this trial is testing

Drivers of Hypoxia-induced Angiogenesis in Tumor Development

Who this might be right for
Von Hippel-Lindau Disease
University of Copenhagen 10
Post-approval studies (Phase 4)UnknownNCT00815594
What this trial is testing

Bleb Vascularity Change After Subconjunctival Injection Bevacizumab

Who this might be right for
Bleb VascularityConjunctival Scarring
Capital Medical University 30
Testing effectiveness (Phase 2)Study completedNCT01028794
What this trial is testing

Autologous Bone Marrow Mononuclear Cell Transplantation for Stroke Patients

Who this might be right for
Cerebral EmbolismStroke
National Cerebral and Cardiovascular Center, Japan 12
Not applicableStudy completedNCT01934465
What this trial is testing

Bevacizumab Plus Chemotherapy for Advanced Non Small Cell Lung Cancer Patients as 1st Line Treatment

Who this might be right for
Non Small Cell Lung Cancer
Hellenic Oncology Research Group 300
Testing effectiveness (Phase 2)Ended earlyNCT01668680
What this trial is testing

Maintenance Metronomic Chemotherapy for Metastatic Colorectal Carcinoma

Who this might be right for
Colorectal Cancer Metastatic
HaEmek Medical Center, Israel 80
Testing effectiveness (Phase 2)UnknownNCT02075086
What this trial is testing

Angiogenic Switch in Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer
Grupo Hospital de Madrid 100
Testing effectiveness (Phase 2)Study completedNCT00694642
What this trial is testing

Safety and Efficacy of Autologous Endothelial Progenitor Cell CD 133 for Therapeutic Angiogenesis

Who this might be right for
Coronary Artery DiseaseRefractory Angina
Pilar Jimenez Quevedo 28
Testing effectiveness (Phase 2)UnknownNCT04469127
What this trial is testing

A Phase I/II Multicenter, Open-Label Study of Lu-177-DOTAGA-IAC, for the Treatment of Angiogenic Breast Cancer Patients.

Who this might be right for
Breast Cancer Stage IV
Advanced Imaging Projects, LLC 100
Not applicableUnknownNCT05383066
What this trial is testing

Anti-angiogenesis Combined With PD-1/PD-L1 Therapy in Patients With Advanced Liver Cancer

Who this might be right for
Carcinoma, Hepatocellular
Peking University First Hospital 490
Not applicableStudy completedNCT00599105
What this trial is testing

Angiogenesis in Early Breast Cancer for Prognosis Prediction

Who this might be right for
Breast Lesions
University of California, Irvine 700
Early research (Phase 1)Study completedNCT00523731
What this trial is testing

ACPs in Severe PAD/CLI by Direct Intramuscular Injection

Who this might be right for
Peripheral Arterial DiseaseCritical Limb Ischemia
TheraVitae Ltd. 6
Testing effectiveness (Phase 2)Ended earlyNCT00667277
What this trial is testing

Phase II Study of Bevacizumab (Avastin®) in Myelofibrosis

Who this might be right for
Myelofibrosis
Ronald Hoffman 13
Very early researchStudy completedNCT01894451
What this trial is testing

Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy

Who this might be right for
Inflammatory Breast Carcinoma
Dana-Farber Cancer Institute 2
Not applicableEnded earlyNCT02511756
What this trial is testing

Visualization of Anti-angiogenic Effects With Perfusion Computed Tomography (CTP)

Who this might be right for
Metastatic Colorectal Cancer
Patrick Veit-Haibach 50
Testing effectiveness (Phase 2)Looking for participantsNCT06446154
What this trial is testing

Fruquintinib After ICIs Treatment in Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaImmune Checkpoint InhibitorsAnti-angiogenic Therapy+1 more
Sun Yat-sen University 36
Testing effectiveness (Phase 2)Study completedNCT00055237
What this trial is testing

Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative Patients

Who this might be right for
Kaposi's SarcomaHIV InfectionsHIV Seronegativity
National Cancer Institute (NCI) 19
Next Page